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Effects of naturally-produced lovastatin on feed digestibility, rumen 
fermentation, microbiota and methane emissions in goats over a 12-week 
treatment period 
ABSTRACT 
Twenty male Saanen goats were randomly assigned to four levels of lovastatin 
supplementation and used to determine the optimal dosage and sustainability of naturally 
produced lovastatin from fermentation of palm kernel cake (PKC) with Aspergillus terreus 
on enteric methane (CH4) mitigation. The effects on ruminal microbiota, rumen 
fermentation, feed digestibility and health of animal were determined over three 
measuring periods (4-, 8- and 12-weeks) and the accumulation of lovastatin in tissues 
was determined at the end of the experiment. The diets contained 50% rice straw, 22.8% 
concentrates and 27.2% of various proportions of untreated or treated PKC to achieve 
the target daily intake level of 0 (Control), 2, 4 or 6 mg lovastatin/kg body weight (BW). 
Enteric CH4 emissions per dry matter intake (DMI), decreased significantly (P<0.05) and 
equivalent to 11% and 20.4%, respectively, forthe 2 and 4 mg/kg BW groups as 
compared to the Control. No further decrease in CH4 emission thereafter with higher 
lovastatin supplementation. Lovastatin had no effect on feed digestibility and minor effect 
on rumen microbiota, and specifically did not reduce the populations of total 
methanogens and Methanobacteriales (responsible for CH4 production). Similarly, 
lovastatin had little effect on rumen fermentation characteristics except that the 
proportion of propionate increased, which led to a decreasing trend (P<0.08) in acetic: 
propionate ratio with increasing dosage of lovastatin. This suggests a shift in rumen 
fermentation pathway to favor propionate production which serves as H+ sink, partly 
explaining the observed CH4 reduction. No adverse physiological effects were noted in 
the animals except that treated PKC (containing lovastatin) was less palatable at the 
highest inclusion level. Lovastatin residues were detected in tissues of goats fed 6 mg 
lovastatin/kg BW at between 0.01 to 0.03 μg/g, which are very low. 
